Impact of a Home-based Heat Therapy Intervention on Markers of Cardiometabolic Function in Adults with Type 2 Diabetes

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Insulin resistance and hyperglycemia predispose individuals with type 2 diabetes mellitus (T2DM) to endothelial dysfunction and a greater risk of cardiovascular diseases (CVD). Increased CVD risk in individuals with T2DM persists despite optimal pharmacological therapy, highlighting the need to identify complementary lifestyle interventions that improve cardiometabolic functions in this population. Evidence from animal models suggests that heat exposure improves metabolic functions. Notably, weekly heat exposure for 16 weeks blunts hyperinsulinemia and hyperglycemia induced by a high fat diet in mice. In parallel, studies in humans have shown that heat exposure improves vascular endothelial function. Based on such findings, it has been suggested that heat therapy may represent an effective lifestyle intervention to improve cardiometabolic functions. However, only 1 study has examined the impact of a heat therapy intervention on individuals with T2DM, demonstrating that 6 weeks of heat exposure reduces fasting plasma glucose and hemoglobin A1C. No study has considered potential vascular benefits of heat therapy in individuals with T2DM. This project will investigate cardiometabolic responses to repeated heat exposure in men and women with T2DM. We will test the hypothesis that 12 weeks of heat therapy improves postprandial fatty acid handling, insulin sensitivity and endothelial function in individuals with T2DM.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Maximum Age: 75
Healthy Volunteers: f
View:

• Age 45-75 years

• Diagnosis of type 2 diabetes mellitus ≥1 year

• Stable medication ≥12 weeks

Locations
Other Locations
Canada
Centre ÉPIC, Montreal Heart Institute
RECRUITING
Montreal
Contact Information
Primary
Daniel Gagnon, PhD
daniel.gagnon.3@umontreal.ca
514-374-1480
Time Frame
Start Date: 2022-02-18
Estimated Completion Date: 2026-12
Participants
Target number of participants: 44
Treatments
Sham_comparator: Thermoneutral
Participants will immerse their feet in a foot bath with water maintained at 36°C
Experimental: Heat
Participants will immerse their feet in a foot bath with water maintained at 42°C
Related Therapeutic Areas
Sponsors
Leads: Montreal Heart Institute

This content was sourced from clinicaltrials.gov

Similar Clinical Trials